Applied Clinical Trials
Metabolic Solutions Development Company announces publication of data ...
Modulating mTOT may represent a new way forward to treat metabolic diseases associated with age-related mitochondrial dysfunction - especially insulin resistance and type 2 diabetes Modulating mTOT may represent a new way forward to treat metabolic diseases associated with age-related mitochondrial dysfunction - especially insulin resistance and ... (more)
Thu May 09, 2013
Takeda Pharmaceutical Co. Ltd. Announces Financial Results for the...
Takeda Pharmaceutical Co. Ltd. Announces Financial Results for the Fiscal Year Ended March 31, 2013 and Forecasts for the Fiscal Year Ending March 31, 2014 .
Mon May 06, 2013
7 Ways to Spend Less on Meds
In fact, people under 65 are twice as likely as older Americans to skip their meds, according to a new Centers for Disease Control study.
Fri May 03, 2013
The Miller Firm helps cancer victim obtain $6.5 million verdict against diabetes drug maker
A Los Angeles jury found that the manufacturer of the popular diabetes drug, Actos, prescribed to 10 million people worldwide, was liable for failure to warn about cancer risks related to that drug.
Judge reverses jury decision over $6.5m Takeda payout
A judge has thrown out the jury's verdict in a case between Japanese drugmaker Takeda and a US man who claims that the company's drug caused his bladder cancer.
Thu May 02, 2013
WEALTHMAKERS.COM Issues Bullish Research Reports on AMAP, BEAT, BKH, CTCH, DVR, FURX
Furiex Pharmaceuticals, Inc., a drug development collaboration company, engages in the compound partnering business primarily in the United States.
Wed May 01, 2013
Effects of co-administration of candesartan with pioglitazone on...
Angiotensin receptor blockers are reported to provide direct protection to many organs by controlling inflammation and decreasing oxidant stress.
Takeda Wins Dismissal of $6.5 Million Diabetes-Drug Verdict in State Trial
Takeda Pharmaceutical Co. persuaded a judge to throw out a $6.5 million jury verdict over its Actos diabetes drug because lawyers for a California man didn't produce sufficient evidence to show his cancer was caused by the medication.
Mon Apr 29, 2013
Huge Plaintiffs' Victory Seen In First Actos Trial
New York, NY, for immediate release: Commenting on a $6.5 million dollar verdict reached this past Friday in a Los Angeles courtroom against Takeda Pharmaceuticals for injuries arising from the plaintiffs' ingestion of Takeda's blockbuster selling diabetes drug, Actos , Napoli Bern Ripka Shkolnik, LLP Senior Partner Hunter Shkolnik described the ... (more)
Sun Apr 28, 2013
The Japan Times
Takeda loses cancer suit over Actos
The government holds its first formal celebration of the day the San Francisco Peace Treaty ended the allied Occupation, angering residents in Okinawa, which stayed under U.S. control until 1972.
Fri Apr 26, 2013
Takeda Responds to Verdict in Diabetes Drug Case
Takeda Pharmaceuticals U.S.A., Inc. announced today that in the case of Jack Cooper et al.
Tue Apr 23, 2013
Take advantatge of big-name drug savings
Consumer Reports checked out prices of atorvastatin at more than 200 pharmacies, including Walgreens, CVS, Target, Walmart, and Costco, as well as independent and supermarket pharmacies and online.
Tart cherries linked to reduced risk of stroke
A class of drugs called PPAR agonists that help regulate fat and glucose was considered promising by doctors who prescribed them for patients with metabolic syndrome -- a collection of risk factors linked to heart disease and type 2. However, studies have shown the long-term use of these drugs can also increase stroke risk, which has prevented many ... (more)
Thu Apr 18, 2013
Drug Savings- 4/7/13
Atorvastatin, the generic for Lipitor, is now widely prescribed to combat high cholesterol.